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PENILAIAN SITOTOKSISITI TERHADAP BATU KARANG YANG TELAH 
DIPROSES KEATAS TITISAN SEL OSTEOBLAS DAN FIBROBLAS 
MANUSIA SECARA IN VITRO 
 
ABSTRAK 
  Tujuan kajian ini dijalankan adalah untuk membuat penilaian ke atas bahan batu 
karang (spesis Porites) yang telah diproses (Kampus Kesihatan, USM) dengan 
mengunakan kaedah proliferasi, kajian apoptosis dan perlekatan sel dengan 
menggunakan titisan sel osteoblas (HOS) dan fibroblas (MRC-5)(ATCC, USA). 
Penilaian sitotoksisiti batu karang yang telah diproses ini adalah mengunakan ujian 
ekstrak dan sentuhan lansung mengikut format ISO 10993-5. Untuk ujian proliferasi, 
HOS sel telah didedahkan kepada dua partikel saiz PNC yang berbeza iaitu  PNC granul 
(0.5-1mm) dan PNC serbuk (1-50μm) dan dianalisa mengunakan  kaedah MTT dan NR 
assai. Sesuatu bahan yang diuji adalah dikatakan toksik sekiranya kadar proliferasi 
adalah kurang daripada 50%. Untuk kajian apoptosis, sel HOS telah didedahkan kepada 
medium ekstrak daripada serbuk PNC  pada kepekatan 200mg/ml selama 48 dan 72 jam. 
Selepas itu sel pelet (1x 10
6 
 sel) dicampurkan ke dalam larutan Annexin-V-FLOUS dan 
dianalisa mengunakan Flow Cytometry. Kajian proliferasi secara sentuhan langsung ke 
atas ceper PNC, adalah menggunakan titisan sel HOS dan  MRC-5. Sel-sel berkenaan 
telah didedahkan kepada bahan PNC pada 1, 24, 72 dan 168 jam dan dianalisa 
mengunakan NR assai. Medium pengkulturan adalah  tidak ditukar selama tempoh 
pengeraman.  Sesuatu bahan yang diuji adalah dikatakan toksik sekiranya kadar 
proliferasi adalah kurang daripada 50%. Untuk kajian perlekatan sel pula, sel MRC-5 
 xiii 
dan HOS telah dikulturkan ke atas ceper PNC dan getah latex (kontrol positif) dan 
pemerhatian adalah dibuat di bawah inverted microscope selepas dieram selama 72 jam. 
Untuk analisis melalui scanning electron microscope (SEM) HOS sel telah dikulturkan 
di atas ceper PNC dan plastik thermanox (kontrol negatif) dan pemerhatian telah dibuat 
selepas pengeraman selama 72 jam.  Kajian proliferasi sel HOS terhadap granul dan 
serbuk PNC menunjukkan kedua-dua partikel berkenaan tidak sitotoksik.  Kedua-dua 
partikel granul dan serbuk PNC tidak merangsang sebarang sitotoksisiti dan telah 
dibuktikan daripada kadar proliferasi yang mana melebihi 50%. Analisa flow cytometry 
telah menunjukkan peratusan sel HOS yang hidup adalah tinggi dan peratusan sel 
apoptotic adalah rendah membuktikan bahan PNC tidak menyebabkan kerosakan kepada 
sel. Keputusan menunjukkan kadar proliferasi sel HOS dan MRC-5 apabila didedahkan 
kepada bahan PNC pada masa pengeraman yang berbeza mengunakan NR assai telah 
menunjukkan tiada ketoksidan terhadap sel sehingga 72 jam masa pengeraman. Kajian 
perlekatan sel, telah menunjukkan sel MRC-5 dan HOS telah melekat pada pinggir ceper 
PNC dan berkembang ke dalam liang-liang ceper PNC. Sebagai kesimpulan, keputusan 
menunjukkan bahan PNC yang telah dihasilkan oleh Kampus Kesihatan, USM adalah 
tidak sitotoksik dan mengalakkan pertumbuhan sel HOS dan MRC-5.  
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IN VITRO CYTOTOXICITY EVALUATION OF PROCESSED NATURAL 
CORAL ON HUMAN FIBROBLAST AND OSTEOBLAST CELL LINES 
 
ABSTRACT 
 
The aim of this study was to evaluate the in vitro cytotoxicity of the locally 
produced processed natural coral (Health Campus, Universiti Sains Malaysia) from the 
Porites species in terms of proliferation, apoptosis study and cell attachment by using 
human osteoblast (HOS) and fibroblast (MRC-5) cell lines (ATCC, USA). The in vitro 
cytotoxicity of the processed natural coral (PNC) was evaluated using test on extract and 
direct contact as per ISO 10993-5 (1999). HOS cells were used to study the magnitude 
of proliferation when exposed to the extraction medium of two different particle sizes of 
PNC, granules (0.5-1mm) and powder (1-50μm). The proliferation of HOS cells was 
analyzed using MTT and NR assays. The material is considered toxic if the proliferation 
rate was less than 50%. For the apoptosis study, HOS cells were exposed to the 
extraction medium of PNC powder at a concentration of 200mg/ml for 48 and 72 hours. 
Then the cell pellet (1x 10
6 
cells) was resuspended in Annexin-V-FLOUS labelling 
solution and subjected to flow cytometric (FCM) analysis. Proliferation study via direct 
contact of PNC disc was carried out using HOS and MRC-5 cell lines. Those cells were 
exposed to the PNC material at 1, 24, 72 and 168 hours and analyzed using NR assay 
and the medium was never changed through out the incubation periods. The material is 
considered toxic if the proliferation rate was less than 50%. For the cell attachment 
study, MRC-5 cells and HOS cells were cultured on the PNC discs and rubber latex 
(positive control) and observed under inverted microscope after 72 hours of incubation 
period. For the Scanning Electron Microscopic (SEM) analysis, HOS cells were cultured 
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on the PNC disc and thermanox plastic (negative control) and observed after 72 hours of 
incubation period. Proliferation study of HOS cells on the extraction of PNC granules 
and powder showed that both particles were not cytotoxic. Also, both PNC granules and 
powder did not induce any cytotoxicity as was evident from their proliferation rate, 
which was above 50%. The flow cytometry analysis showed that the viable cell 
percentage for the HOS cells was high and the apoptotic cell percentage was low, 
indicating that PNC did not cause a remarkable damage to the cells. The results of the 
magnitude of proliferation of HOS and MRC-5 cells when exposed to the PNC material 
at different incubation periods using NR assay indicated that there was no cytotoxicity 
until an incubation period of 72 hours. The cell attachment study showed that both 
MRC-5 and HOS cells were attached on the edge of the PNC disc, which later grew into 
the pores of the PNC disc. All the above results show that the locally produced PNC 
material by Health Campus, Universiti Sains Malaysia is non cytotoxic and favours the 
growth of HOS and MRC-5 cells. 
 
 1 
CHAPTER ONE 
INTRODUCTION 
1.1 Background of the study  
The development of bone-graft substitutes has evolved from the understanding of 
how autografts and allografts are used intraoperatively and how they are remodelled by 
the body after transplantation. Bone formation requires a physical structure to which 
osteoblasts can adhere. Therefore, the concept of using porous devices composed of 
biocompatible materials was conceived. The earliest work used inert metals, such as 
cobalt chrome and titanium alloy. These materials can provide passage ways  for bone  
integration, but bone cell does not directly bond to proliferate along their surfaces 
(Shors, 1999).  
Osteogenesis, osteoinduction and osteoconduction are the essential elements of 
bone regeneration along with the final bonding between host bones and grafting material 
which is called osteointegration. The term osteoconduction means that bone grows on a 
surface. An osteoconductive surface is one that permits bone growth on its surface or 
down into pores, channels. The term osteoinduction means that primitive, 
undifferentiated and pluripotent cells are somehow stimulated to develop into the bone-
forming cell lineage (Giannoudis et al., 2005). The different characteristics of bone graft 
substitutes are shown in table 1.1.  
 Biomaterials or scaffolds for osteogenesis should mimic bone morphology, 
structure and function in order to optimize integration into surrounding tissue. Bone is a 
structure of hydroxyapatite (Ca10(PO4)6(OH)2) crystals deposited within an organic 
matrix in which 95% is type 1 collagen. The morphology is composed of trabecular 
 2 
bone, which creates a porous environment with 50 – 90% porosity (Karageorgiou and 
Kaplan, 2005).  
 
Table 1.1 Characteristics and bone graft substitutes 
Characteristics Grafts 
Osteoconduction Calcium sulphate 
Calcium phosphate cements 
Ceramics  
Collagen 
Synthetic polymerss 
Osteoinduction DBM 
BMPs 
Growth factors 
Genetic therapy 
Osteogenesis 
combined 
Bone marrow aspirate (BMA) 
Composite graft 
 
The necessity for porosity in bone regeneration has been shown by Kuboki et al. 
(1998) using rat ectopic model, whereby solid and porous particles of HA were used for 
BMP-2 delivery. They found that no new bone was formed on the solid particles, while 
in the porous scaffolds, direct action of osteogenesis occurred. 
Scaffolds for bone regeneration should meet certain criteria to serve the skeletal 
functions including mechanical properties similar to those bones at the repair site, 
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biocompatibility and biodegradability appropriate with remodelling (Karageorgiou and 
Kaplan, 2005). Scaffolds serve primarily as osteoconductive moieties, since new bone is 
deposited by creeping substitution from adjacent living bone. In addition to 
osteoconductivity, scaffold can serve as a delivery vehicle for cytokines such as bone 
morphogenetic proteins (BMPs), insulin-like growth factors (IGFs) and transforming 
growth factors (TGFs) that transform recruited precursor cells from the host into bone 
matrix producing cell, thus providing osteoinduction (Groeneveld et al., 1999).  
The success of implanted device is affected by the ability of cells to interact with 
the exposed device material because properties such as surface topology are stable 
features of the surface, compared to chemical modifications device which may be 
degraded over time. There has been immense interest in directing cell behavior by 
controlling the topology of materials. Cells have been found to respond differently to 
smooth surfaces compared to materials with micro or nanoscale roughness in a cell type 
dependent manner (Jiyeon  et al., 2008). 
The research on natural coral as a bone substitute has been reported in many 
experimental studies. It has been proven to be biocompatible, biodegradable and has not 
been found to cause any inflammatory responses (Tuominen et al.,  2000). Coral is made 
of calcium carbonate (98-99%) in the form of aragonite with the trace elements and 
amino acid (Louisia  et al., 1999). It has been used as a biomaterial for bone replacement 
because of several reasons such as, the material simplifies the surgical procedure, 
harvesting of autologous bone is no longer necessary and transmission of infections such 
as AIDs, and hepatitis can be avoided with certainty. Furthermore, coral has porous 
architecture, high compression breaking stress and resorbability. It has been reported 
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that the porosity and three-dimensional structure of coral implant encourage bony 
ingrowth (Marchac et al., 1994).  
Natural coral is a bone graft substitute, which has been widely used in 
maxillofacial, orthopaedic, ORL and periodontal surgery. The capacity of coral to 
disappear and to be substituted by new bone distinguishes it from non-resorbable 
materials extensively used in these surgeries. An optimal clinical utilization of coral 
requires a thorough knowledge of factors influencing resorption, particularly regarding 
the interface between implant and connective tissue, which is larger than the surface in 
contact with the bone
 
(Guillemin et al., 1989).  
Coral mineral has had considerable success considering its porous structure 
(which ranges from 150 to 500μm), its similarity to cancellous bone and also because it 
is one of a limited number of materials that will form chemical bonds with bone and soft 
tissue in vivo. Studies indicate that a favorable pore size and micro-structural 
composition are important factors facilitating in-growth of fibrovascular tissue or bone 
from the host. Pore interconnection sizes are utmost importance when hard and soft 
tissue in-growth is involved (Ben-Nissan, 2003). 
The structure of the commonly used natural coral porites species is similar to that 
of cancellous bone and its initial mechanical properties resemble those of bone. It is also 
an osteoconductive material
 
(Shahgaldi, 1998). Bone grafting mediated via tissue 
engineering of stem cells for repairing defects represents a new direction towards bone 
regeneration in this millennium. Natural coral has found considerable interest as scaffold 
materials (Parfitt, 2000).  
All newly developed biomaterials must fulfilled stringent criteria laid out by 
government authorities and international agencies, such as the United States Food and 
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Drug Administration (FDA) and International Organisation for Standardization (ISO), 
before receiving approval for clinical application (Gallagher et al., 2006). 
ISO is a worldwide federation of national standard bodies (ISO member bodies). 
The work of preparing International Standards is normally carried out through ISO 
technical committee. The International standards ISO 10993-part 5 “Biological Testing 
of Medical devices-Part 5: Test for in vitro cytotoxicity” was prepared by technical 
committee ISO/TC 194, Biological Evaluation of Medical Devices. The crucial 
parameters for cytotoxicity testing are addressed but not specified in ISO, 10993-5 
(1999).  
 In practice, standard cell-based toxicity assays are performed in vitro and high-risk 
materials are removed at this early stage. This method has the advantages of simplicity, good 
sensitivity and reproducibility and is widely used in the initial evaluation of biocompatibility of 
biomaterials (Gallagher et al., 2006). 
 
1.2 Problem statement  
Virtually, every operative day, orthopedists, neurosurgeons, maxillo-craniofacial 
surgeons and periodontists need to fill defects in bone or augment deficient bone. When 
the defect is small, an autologous bone graft is the best solution but in  larger defects, the 
addition of homologous bone graft and biomaterials are a necessity. Recent advances in 
orthopaedic and maxillo-craniofacial surgery can be attributed to the revolution in 
biomaterials. During the last decade, a large number of biomaterials have been proposed 
as artificial bone filler for repairing bone defect (Shors, 1999)  
Bone graft is the second most common transplantation tissue, next to blood. 
More than 500,000 bone grafting prosedures are happening annually in the United States 
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and 2.2 million worldwide in order to repair bone defects in orthopaedic, neurosurgery 
and dentistry (Giannoudis et al., 2005).  
The coral of Porites species possess anatomical structure, physical, chemical and 
mechanical characteristics that stimulate the human bone. The material is acceptable by 
people from all races, ethnicity, religious and belief. The material is economical and 
affordable to patients and this will help to reduce the cost and increase the quality of 
health care in the country (Hamid et al., 2005).    
 
1.3 Justification of the study   
This study was carried out using a dead coral identified by Universiti Sains 
Malaysia (USM), Health Campus, isolated from Porites species. Dead coral of Porites 
species was processed at the Tissue Bank Unit of USM. The specimen was collected 
from Pulau Perhentian, Terengganu and the species was identified by marine biologist 
Prior approval was obtained from Department of Fisheries, Malaysia (Appendix).  
 In this present study, The coral of Porites species was chosen because the 
interconnectivity between its pores was quite similar to that of the human cancellous  
bone.  An in vitro cytotoxicity test was carried out on this processed natural coral (PNC) 
on human osteoblast (HOS; CRL-1543) and human embryonic lung fibroblasts (MRC-5; 
CCL-171) cell lines (ATCC, USA) by using extraction/indirect method and direct 
methods. Two different types of cell lines were used in this study; HOS cell line which 
corresponds to hard tissue and MRC-5 cell line which corresponds to soft tissue.  
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1.4 Objectives of the study 
 
1.4.1 General objective 
The objective of this study is to evaluate the in vitro cytotoxicity of processed natural 
coral as a bone substitute. 
 
1.4.2 Specific objectives  
1. To determine the cytotoxicity effects of different particle sizes of processed natural 
coral on the proliferation of human osteoblast cell line 
2. To assess the apoptosis of human osteoblast cell line on the extract of processed 
natural coral material 
3. To determine the cytotoxicity effects of processed natural coral on the proliferation of 
human lung fibroblast and human osteoblast cell lines based on different incubation 
periods. 
4. To study the attachment of the human osteoblast and human lung fibroblast cell lines 
on the processed natural coral material 
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CHAPTER TWO 
LITERATURE REVIEW 
2.1 Definition of Biomaterials  
The definition of biomaterial endorsed by consensus of experts in this field is 
that “a biomaterial is a nonviable material used in a medical device, intended to interact 
with biological systems” (Ratner, 1996). The first reported use of synthetic biomaterial 
in facial plastic and reconstructive surgery occurred around 1600 when Fallopius 
implanted a gold plate to repair a calvarial defect (Costantino et al., 1993).  
Biomaterials have been used extensively in orthopaedic surgery, craniofacial and 
maxillofacial surgery, biomedical engineering and more recently, the delivery of 
therapeutic agents. Many definitions have been proposed for the term biomaterial. 
According to Dorland (2000), biomaterials are substances (other than drugs), synthetic 
or natural, that can be used as a system or part of a system that treat, augment or replace 
any tissue, organ or function of the body.  
 
2.2 Historical development of biomaterials  
The ancient Chinese and the Aztec used gold in dentistry for more than 2000 
years ago. Perhaps the most widely used class of material is metals for implants. For 
instance, some of the most common orthopedic surgeries involve the implantation of 
metallic implants. These range from simple wires and screws to fracture-fixation plates 
and total joint prostheses.  Aluminium, platinum, and nikel-plated devices were used as 
screws. By the early 20
th
 century, high-carbon steel was used for these purposes. Cobalt-
chromium alloys were introduced in the 1920s and titanium came into vogue in the late 
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1940s. Currently, the most commonly used metals for orthopaedic implants are low-
carbon stainless steel and cobalt-chromium alloy (Agrawal, 1998).   
Stainless steel is used extensively for fracture fixation devices. Compared to the 
other metals used in orthopedic, stainless steel exhibit a moderate to high elastic 
modulus and tensile strength. Stainless steel is fairly biocompatible although they never 
appear to fully integrate with bone tissue. Cobalt-chromium alloys are highly corrosion 
resistant. Compared to stainless steel, they exhibit higher elastic modulus, strength and 
hardness, but they have relatively low ductility and are difficult to machine. Titanium is 
used in two forms; commercially pure titanium and Ti-6A1-4V. Pure titanium is 
relatively weak (Agrawal, 1998).   
At the turn of this century, synthetic plastic became available. Their ease of 
fabrication led to many biomaterial experiments. Most of these, were doomed to failure 
due to  the light of our contemporary understanding of biomaterials toxicology (Ratner, 
1996). The popularity of biodegradable polymers as biomaterials has been steadily 
increasing in the past two decades. The beauty of these materials is that they can be 
designed as temporary implants that stay intact until the healing process in the body is 
complete, whereupon they degrade by hydrolytic or enzymatic action and excreted from 
the body as waste products. The most popular biodegradable polymers are polylactic 
acid (PLA) and polyglycolic acid (PGA) (Agrawal, 1998).  
A variety of polymers are used in medicine as biomaterials. Their applications 
range from facial prostheses to tracheal tubes, from kidney and liver parts to heart 
components, and from dentures to hip and knee joints. Polymethyl methacrylate  
(PMMA) was introduced in dentistry in 1937. During the World War II, debris of 
PMMA from shattered gunnery turrets, accidentally implanted in the eyes of aviators 
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suggested that some of these materials evoked only mild foreign body reaction (Ratner, 
1996). In this century, PMMA was used extensively as bone cement which is primarily 
used to support the stems of total joint prostheses in the medullary cavity of bone 
(Agrawal, 1998). 
Gruninger et al. (1984) introduced the term “calcium phosphate cement” which 
can be prepared by mixing a calcium phosphate salt with water or an aqueous solution to 
form a paste that reacts at room temperature. The cement is applicable in grafting and 
reconstruction of damaged parts of the body system. Yu et al. (1992) found that calcium 
phosphate cements can be used as drug delivery systems for a variety of remedies and 
act as a vehicle for antibiotics, anti-tumor and anti-inflammatory drugs. Despite the wide 
range of possible clinical applications of calcium phosphate cements, there are very few 
literature reports on its in vitro biocompatibility.  
Diamond-like carbon films (DLC) have been studied extensively for military 
applications as a single-layer antireflection coating for infrared vision system 
(Lettington and Smith, 1992). DLC film has attracted much attention in recent years 
because of its hardness, wear resistance, chemical inertness and low coefficient of 
friction. Thomson et al. (1991) were the first few authors to study the biological effects 
on DLC films. Du et al. (1998) studied the morphological behavior of osteoblasts cells 
on DLC coatings in vitro and they found that after a period of time the cells attached, 
spread and proliferated on the DLC coated film. 
Several materials derived from the animals or plant is also being considered for 
use as biomaterials. One of the advantages of using natural materials for implants is that 
they are anatomically similar to materials familiar to the body. Natural materials do not 
usually offer the problem of toxicity often faced by synthetic materials. They may also 
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carry specific protein binding sites and other biochemical signals that may assist in 
tissue healing or integration. However, natural materials can be subjected to problems of 
immunogenicity. Collagen has been studied extensively for use as a biomaterial. It has 
shown good promise as a scaffold for new tissue growth and is commercially available 
as a product healing. Other natural materials under consideration include chitin, keratin, 
cellulose and natural coral (Amarjit et al., 2003). 
 
2.3 Characteristic of an ideal biomaterial as a bone substitute  
Screening for an ideal biomaterial for bone substitute is still a challenge for 
researchers.  An ideal biomaterial should be osteoconductive, osteoinductive and porous 
for cellular infiltration. Furthermore, it should be biocompatible, mechanically stable 
with respect to the native bone and be biodegradable to prevent having foreign material 
in the body for prolonged period of time. Other considerations include ease of 
sterilization without loss of properties (Tortora and Grabowski, 2000). 
Bone is not completely solid but has many small spaces between its hard 
components. Some spaces provide channels for blood vessels that supply bone cells with 
nutrients. Other spaces are storage areas for red bone marrow. Depending on the size 
and distribution of the spaces, the regions of a bone may be categorized as compact or 
spongy. Overall, about 80% of the skeleton is compact bone and 20% is spongy bone 
(Tortora and Grabowski, 2000). 
Bone matrix contains abundant of inorganic mineral salts, primarily   
hydroxyapatite (HA) and some calcium carbonate. In addition, bone matrix includes 
small amounts of magnesium hydroxide, fluoride and sulfate. As these minerals salt are 
deposited in the framework formed by the collagen fibers of the matrix, they crystallize 
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and the tissue hardens. This process of calcification or mineralization is initiated by 
osteoblasts (Tortora and Grabowski, 2000). 
The organic components including cell, collagen, and various macromolecules 
have the capacity to initiate immune responses.  The inorganic component, however, is 
biocompatible and nonimmunogenic. These calcium salts, primarily calcium phosphate, 
constitute approximately 70% of bone by weight. The major constituent is in the form of 
a poorly crystalline calcium phosphate compound, known as HA. Calcium salt, 
particularly HA and calcium carbonate are bioactive and osteoconductive (White and 
Shors, 1986). 
Porosity allows soft tissue and bone to regenerate within the pore space. Porosity 
alone however is not adequate for bone ingrowth. Porosity with interconnectivity is the 
most essential prerequisite (White and Shors, 1986). Pore size is important in 
determining cellular ingrowth, factor release and vasculirization. White and Shors 
(1986) reported that the requisite pore size for bone ingrowth into porous implants is 100 
to 500um. Material scientists at the Clemson University in the early 1970s conducted 
seminar studies. They showed that the diameter of the interconnecting pore dictate the 
kind of tissue growing into the porosity of implant place next to the bone. To generate 
mineralized bone, the interconnecting must be larger than 100um. If they are 40 to 
100um, osteoid forms and if they are 10 to 40um, fibrovascular tissue forms (White and 
Shors, 1986) 
There has been conflicting studies on the size of the pores of biomaterial that will 
influence the bone formation.  Pinade et al. (1996) recommended that pore sizes up to 
200um will achieve the bone growth while Burg et al. (2000) have claimed that an 
interconnecting pore size of  200-400um is the optimum pore size for  bone ingrowth. 
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Kuhne et al. (1994) investigated the new bone formation between two different pore size 
of coralline hydroxyapatite (HA500 and HA200) by using rabbit model. They found that 
the new bone formation in coralline hydroxyapatite (HA 500) with pore size 500um is 
faster than in coralline HA (HA200) with the pore size 200um. They concluded that, 
500um pore size hydroxyapatite may be suitable as bone substitute in metaphyseal 
defects. 
Gao et al. (1997) investigated the effect of tricalcium phosphate (TCP) and 
Biocoral
®
(natural coral) cylinder on bone regeneration during the healing of segmental 
defects of sheep in terms of radiomorphometry, histology and biomechanics. They 
compared the osteointegration and mechanical strength of the two different kinds of 
bioceramics and found that biocoral had better osteointegration and biomechanical 
performance than TCP. The three-dimensional structure of pores and interconnecting 
fenestrations in Biocoral as compared to TCP might be more favorable for new bone 
ingrowth. 
 
2.4 Coral for medical application 
Marine reefs are primarily composed of corals and exist in two forms: as a soft 
form without significant inorganic structure and as a hard form which is called stony 
corals or scleractina. These scleractina corals are colonies of many individual animals 
called polyps, which is derived originally from a single animal. The polyp, an 
invertebrate grow most aggressively in warm, shallow along the equator. The polyps 
deposit an interconnecting, porous skeleton composed primarily of calcium carbonate 
form of aragonite. As the polyps grow, they vacate their skeleton leaving behind a 
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network of interconnecting porosity, which has the correct pore size for bone ingrowth 
(Shors, 1999) 
The species of marine invertebrates exploited in medical applications are presented in 
Table 2.1.  Porites and Goniopora species, belonging to the Poratidae family, are widely 
used as a coral grafts and also for developing coralline HA bone substitute implants 
(Damien and Revell, 2005). The Image of Porites and Goniopora species are shown in 
Figures 2.1 and 2.2. (www.reefcorner.com/). 
 
Table 2.1 Classification of corals in biomedical use 
                                                                       Coral Taxonomy 
Kingdom                                                        Animalia 
Phylum                                                           Coelenterata 
Order                                                              Scleractenia 
Family                                                            Paratidae 
Genera                                                            Porites  species 
                                                                       Goniopora species 
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Figure 2.1 Image of Porites species  
 
Figure 2.2 Image of Goniopora species 
 
Since, these skeletons are composed primarily of calcium carbonate, material 
scientists in mid-1970s used these coral skeletons as templates for making bone-graft 
substitutes. The implant is called coralline and manufactured in two forms. One 
approach is to use coral directly in the calcium carbonate form and termed as natural 
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coral. The other form is conversion of calcium carbonate to hydroxyapatite and termed 
as replamineform (Shors, 1999). 
Replamineform ceramics are made from natural coral. Coral is composed of 97% 
calcium carbonate, but is structurally similar to bone. Two common types of coral, by 
genus, have structures that emulate cancellous and cortical bone, respectively. 
Goniopora species creates a structure with 500-600um pores and 220-260µm 
interconnections. This ‘trabecular pattern’ is similar to cancellous bone, with 20% 
matrix and the rest ‘marrow space’ (Kurz et al., 1989). Porites on the other hand, is 
similar to cortical bone with 200-250µm pores and parallel channel connected by 190µm 
fenestrations. Unlike the random pores structure of sintered ceramics, the unique 
structural geometry of coralline promotes rapid resorption and reossification. One form 
of replamiform ceramic employs hydrothermal exchange to replace calcium carbonate 
with calcium phosphate (Lebwohl et al., 1994). This material, marketed as Pro-Osteon 
(Interpore, Irvive, CA), is essentially coralline HA. Both forms are extremely 
biocompatible. An incompletely converted, calcium phosphate and calcium carbonate 
material, termed Pro-Osteon 500R, is being investigated for a potentially more 
predictable profile (Truumees and Herkowitz, 1999). 
A large number of biomaterials have been used as artificial bone substitutes for 
repairing bone defects such as hydroxyapatite, tricalcium phosphate, polymer and 
bioactive glasses. Roux et al. (1988) reported that coral was frequently used in 
maxillofacial surgery during 1980s  but its  use became rarer during the last few years. 
This is perhaps due to  difficulty of using this material, as it is brittle and rough, but 
more probably because in clinical use the variations in the porosity values have not been 
taken into account according to the species. All coral species secrete calcium carbonate 
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in the form of aragonite, but each species constructs an original architecture which 
results in a unique porosity (Roudier et al., 1995). 
According to Guillemin et al. (1987) and Shors et al. (1989),  certain coral 
species are rapidly resorbed after implantation. Experiments in vitro and in vivo to 
characterize the behavior of resorption of bone implanted with  three different  coral 
materials was conducted  by Roudier et al. (1995)  and  they found that the porosity 
plays the important role to influence the speed of  resorption.  Biocompatibility for 
living cells was studied in vitro by seeding the developing differentiated bone marrow 
cells and they observed that osteoblastic cells grew and maintained their in vitro 
differentiation on the material for more than a month. 
 
2.5 Applications of tissue engineering 
Despite the many advances in bone graft substitutes, new materials and 
approaches to bone healing continue to be investigated. One exciting area is tissue 
engineering, which can be defined as the application of biological, chemical, and 
engineering principles to the repair, restoration, or regeneration of living tissues by using 
biomaterials, cells, and biological factors alone or in combination. Tissue engineering is 
a new development in biomedicine, involving a series of strategies and the key element  
is the use of biologically based mechanisms in order to repair and heal damaged and 
diseased tissue. The key elements include a specific living cell type (or several cell 
types),  a biomaterial as a scaffold  that form a supportive structure for culturing cells  in 
vitro and surgical delivery in vivo to the patient. For the majority of mammalian cell 
type, a growth stimulus is also required to control the differentiation of cells into the 
appropriate cell linage and to promote their proliferation (Di-Silvio et al., 2003).  
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Osteoblasts, chondrocytes and mesenchymal stem cells obtained from patient’s 
hard and soft tissues can be expanded in culture and seeded onto scaffold that will 
slowly degrade and resorb as the tissue cultures grow in vitro and/or in vivo (Langer and 
Vacanti, 1993). The scaffold or three-dimentional (3-D) construct provides the necessary 
support for cells to proliferate and maintain their differentiated function and its 
architecture defines the ultimate shape of the new bone and cartilage. Several scaffold 
materials have been investigated for tissue engineering of bone and cartilage including  
hydroxyapatite, poly(α-hydroxyesters) and natural polymer such as  collagen and chitin 
(Di-Silvio et al., 2003). 
 
2.6 Nanotechnology 
After years of evolutionary research, nanoscience and nanotechnology can 
address one of the greatest challenges in the post-genomic era of the 21st century. 
Nanotechnology in the life science is omnipressent. Several biological systems operate 
at the nanoscale with remarkable precision and regulation. A fine example is that of 
biomolecular motor proteins, designed by nature to carry out critical functions in the 
cell. Most of the properties of these proteins are nanoscale.  A similar situation is 
encountered with biomaterials, another area with tremendous application potential where 
novel materials are being created by material designer based on inspiration from 
complex nanobiological systems (NSTI, 2005). 
The ability to mimic the dimensions of constituent components of natural tissues, 
like proteins, nanophase materials may be an exciting successful alternative. Nanophase 
materials are defined as materials with constituent dimension less than 100nm in at least 
one direction. Materials investigated to date include nanophase ceramics, metals, 
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polymers and composites. Nanophase materials may be optimal materials for tissue 
engineering applications which is not only due to their ability to stimulate dimensions of 
proteins that comprise tissues, but also because of their higher reactivity for interactions 
of proteins that control cell adhesion and, thus, the ability to regenerate tissue (NSTI, 
2005). 
 
2.7 Medical devices 
A medical device is defined as any instrument, apparatus, of other article that is 
used to prevent, diagnose, mitigate or treat a disease or to affect the structure of function 
of the body with the exception of drug (SMDA, 1990). It has been agreed that 
biomaterials are also considered as a medical device. Thus, medical device has 
extremely large item and biomaterial is classified either as class II or class III depending 
on the regulation in the particular activity. The classification according to Food and 
Drug Act (FDA) is as follows: 
a) Class I: 
Wheel chairs, patient electrode, Scalpels, dental drills, wound management systems, 
hearing aid tester. 
b) Class IIa: 
All patient monitoring equipments, syringes, needles, ultra sound devices, external 
ECGs, diagnosis devices. 
c) Class IIb: 
Laser devices for applications, internal ECGs, non-energized implants, treatment 
devices. 
d) Class III: 
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Energized implants, all Intracardiac applications, heart valves, catheters, non-energized 
implants, all devices in contact with the central nervous system (CALISO, 2006).  
 
2.8 Biosafety of Medical devices 
2.8.1 Biocompatibility of biomaterials 
Biocompatibility is generally defined as the ability of a biomaterial or medical 
device to perform with an appropriate host response in a specific application (Anderson, 
2008). Bioresponse or biocompatibility assessment (i.e. evaluation of biological 
responses) is considered to be a measure of the magnitude and duration of the adverse 
alterations in homeostatic mechanisms that determine the host response. From a 
practical view, the evaluation of biological responses to a medical device is carried out 
to determine that the medical device performs as intended and presents no significant 
harm to the patient (Anderson, 2008).   
Kirkpatrick et al. (1997) reported that biocompatibility involved two principle areas. 
The first is the principle of ‘biosafety’ which involves the exclusion of severe deleterious effect 
of the biomaterial on the organism. This encompasses both cytotoxicity and the field of 
mutagenesis and carcinogenesis. The second area is   the ‘biofunctionality’ which deals with the 
ability to perform with the appropriate host response in a specific application.   
 
2.8.2 Cytotoxicity testing in vitro 
Definition of cytotoxicity means to cause toxic effects such as cell death, 
alteration in cellular membrane permeability, enzymatic inhibition at  the cellular level.  
A toxic material is defined as a material that releases a chemical in sufficient quantities 
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through inhibition of key metabolic pathway. The number of cells that are affected is an 
indication of the dose and potency of chemical (Northup, 1993). 
Cytototoxicity tests are recommended for all medical devices because 
(i) they allow for rapid evaluation, 
(ii) standardized protocols are employed,  
(iii) quantitative and comparable data are produced and  
(iv) due to their sensitivity, they allow for discarding toxic materials prior to animal 
testing.  
The categories of test are listed as an extract test, direct-contact test and indirect-
contact test. Experimental studies have demonstrated that good correlation between in 
vitro and in vivo tests, thus confirming the usefulness of in vitro tests as systems to 
select the materials (Freshney, 2000). 
Many experiments carried out in vitro are for the sole purpose of determining the 
potential cytotoxicity of the compounds being studied, either because the compounds are 
being used as pharmaceuticals or cosmetics and must be shown to be nontoxic or 
because they are designed as anticancer agents and cytotoxicity may be crucial for their 
action (Freshney, 2000). 
 
2.8.2.1 Nature of cytotoxicity assay 
The choice of assay will depend on the agent under study, the nature of the 
response, and the particular target cell. Assays can be divided into five major classes: 
 a)Viability 
Viability assays are used to measure the proportion of viable cells following a 
potentially traumatic procedure, such as primary disaggregation, cell separation, or 
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freezing and thawing. Most viability tests rely on a breakdown in membrane integrity 
that is determined by the uptake of a dye to which cell is normally impermeable (e.g., 
trypan blue, erythrosin, naphthalene black) or the release of a dye normally taken up and 
retained by viable cells (e.g., diacetyl fluorescein or neutral red). However, this effect is 
immediate and does not always predict ultimate survival (Freshney, 2000). 
b) Survival  
  Short term tests are convenient and usually are quick and easy to perform. They 
reveal only cells that are dead (i.e., permeable) at the time of the assay. Frequently, 
however, cells that have been subjected to toxic influences (e.g., irradiation, 
antineoplastic drugs) show an effect several hours, or even days, later. The nature of the 
tests required to measure viability in these cases is necessarily different, since by the 
time measurement is made, the dead cells may have disappeared. Therefore, long term 
tests are used to demonstrate survival rather than short term toxicity, which may be 
reversible. Survival implies the retention of regenerative capacity and is usually 
measured by plating efficiency (Freshney, 2000). 
c) Metabolic 
Metabolic assay is usually microtitration based, of intermediate duration that can 
either measure a metabolic response (e.g., dehydrogenase activity, DNA, RNA or 
protein synthesis) at the time of, or shortly after, exposure, or measure the same 
parameter two or three population doublings after, exposure, when it is more likely to 
reflect cell growth potential  and/or  survival (Freshney, 2000). 
d) Transformation 
Transformation is associated with genetic instability  and three major classes of 
phenotypic change, one or all of which may be expressed in one cell strain: 
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i)   Immortalization, the acquisition of an infinite life span 
ii)  Aberrant growth control, the loss of contact inhibition and anchorage dependence  
iii) Malignancy, as evidence by the tumorigenic potential of the cells 
The characteristic of a cell line do not always remain stable. Normal, human 
finite cell lines are usually genetically stable but cell lines from other species, 
particularly the mouse are genetically unstable and transform quite readily (Freshney, 
2000). 
e) Irritancy 
A response analogous to inflammation, allergy or irritation in vivo; as yet 
difficult to model in-vitro, but may be possible to assay by monitoring cytokine release 
in organotypic culture (Freshney, 2000). 
 
2.8.3 Biocompatibility testing 
2.8.3.1 MTT assay 
Several indirect methods are commonly used for the measurement of cell 
viability, cytotoxicity and cell proliferation. These assays are simple, rapid and well 
suited for the analysis of large number of sample in 96-well microtitre plates. These 
methods are usually based on the measurement of an enzymatic activity which reflects 
the general metabolic status of cell.  One of the best known is the 3-[4,5-
dimethylthiazol-2y]-2-5-diphenyltetrazolium bromide (MTT) assay. The MTT assay is 
quantitative calorimetric assay based on the cleavage of the yellow water-soluble 
tetrazolium salt, MTT, to form water-insoluble, dark-blue fomazan crystals.  MTT 
cleavage occurs only in living cells by the mitochondrial enzymes succinate 
dehydrogenase. The formazan crystals are solubilised using suitable organic solvent, 
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usually isopropanol, and the optical density of the resulting solution is measured using 
spectrophotometer. The absorbance is directly proportional to the concentration of the 
blue formazan solution, which is in turn proportional to the number of metabolically 
active cells (Mosmann, 1983). 
2.8.3.2 Alkaline phosphate assay 
An alternative indirect method for measurement of cell number is the alkaline 
phosphate assay which is based on conversion of non-fluorogenic substrate 4-methyl 
umbelliferyl phosphate to the fluorescent product 4-methyl umbelliferylone by the 
widely distributed enzyme alkaline phosphatase (Freshney, 2000). 
2.8.3.3 Neutral red assay 
Neural red uptake assay, initially described by Finter, (1969) is being used 
commonly in biochemical and immunological studies and it has also been adopted as a 
recommended method for qualitative assessment of biomaterial safety by some national 
agencies for normalization of testing (AFNOR, 1988).  The neural red assay quantifies 
the number of viable cell after exposure to toxicants and based on the cellular uptake of 
the dye which passes through intact membranes of viable cells and is concentrated in the 
lysosomes. 
However, neutral red is not retained by nonviable cells. Uptake of neutral red is 
quantified by fixing the cells in formaldehyde and solubilizing the stain in acetic 
ethanol, allowing the plate to be read on an ELIZA plate reader at 570nm. Neutral red 
tends to precipitate, so the medium with stain is usually incubated overnight and 
centrifuged before use. This assay does not measure the total number of cells, but it does 
show a reduction in the absorbance related to loss of viable cells and is readily 
automated (Fotakis and Timbrell, 2006). 
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2.8.3.4 Direct measurement of mitogenetic activity in cell culture  
a)  [
3
H] thymidine into acid-insoluble materials 
This is a direct method which is used for measuring the mitogenic activity of a 
growth factor in any adherent or non-adherent cell type, which can be made to arrest in 
G0  or G1 phase of the cell  cycle after suitable period of cell  culture or serum 
deprivation (Freshney, 2000). 
b) Autoradiography of labelled nuclei  
This method measures the incorporation of [
3
H]thymidine into nuclei 
autoradiographically by exposing the labeled cell into film. As the sensitivity of this 
method is less than that of scintillation counting of [
3
H]thymidine incorporated into 
acid-insoluble material, a higher specific activity of radiolabelled precursor is used, 
usually  5µCi ml
-1
[
3
H] thymidine. The exposure to such cells to a high level of 
radioactivity causes DNA damage resulting in arrest of cells after S  phase (Freshney, 
2000). 
c) BrdU incorporation and staining 
This method measures incorporation of the thymidine analogue BrdU into DNA. 
BrdU is detected by immunocytochemistry using anti-BrdU antibody, or  commonly  
using fluorescent DNA-binding dyes such as Hoechst 33258, whose fluorescence is 
quenched by BrdU (Freshney, 2000).  
 
2.8.4 Genotoxicity testing 
The identification of substances capable of inducing mutations has become an 
important procedure in safety assessment. Chemicals that can induce mutations can 
